Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Phase IIIb results support use of diquafosol in dry eye

Aug. 20, 2003

AlphaCor introduction for cornea transplant patients who reject human tissue

Aug. 20, 2003

Santen seeks Japanese manufacturing approval for vernal keratoconjunctivitis treatment

Aug. 18, 2003

ISTA files second Vitrase NDA

Aug. 7, 2003

Squalamine improves visual outcomes in phase I/II wet AMD study

Aug. 6, 2003

Priority review for diquafosol tetrasodium NDA

Aug. 5, 2003

IGF-I peptides useful in ophthalmology and dermatology

Aug. 4, 2003

IOP-lowering agents prepared and tested by Alcon researchers

July 28, 2003

CG-5601, a potential alternative to thalidomide for ocular inflammation

July 11, 2003

Minimal VEGF exon 6-encoded sequence with antiangiogenic activity identified

July 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...